Down 50% to C$0.005: MYTC.CN MyndTec Inc. (CNQ) 09 Feb 2026 monitor liquidity

The MYTC.CN stock plunged 50.00% to C$0.005 in market hours on 09 Feb 2026, a sharp move on thin volume that highlights liquidity risk for small-cap healthcare names. We note the intraday range C$0.005–C$0.01 and volume of 25,000 shares versus average 7,864, which pushed price averages well below the 50-day (C$0.0183) and 200-day (C$0.06108) moving averages. This article breaks down valuation, trading metrics, Meyka AI grading and a model forecast to help investors weigh risk and the limited upside ahead.

Market sell-off snapshot for MYTC.CN stock

MyndTec Inc. (MYTC.CN) traded on the CNQ in Canada and closed at C$0.005 after a -50.00% one-day move. The sell-off followed a low liquidity session where volume 25,000 was 3.18x the average, amplifying downside pressure. The stock is near its year low C$0.005 while the year high remains C$0.15, underlining wide historical volatility.

Valuation and financials: what the numbers say

MYTC.CN shows a market cap of C$156,123.00 and trailing EPS of -0.04, producing a negative PE of -0.12. Price-to-sales sits at 1.18 and EV/sales at 3.74, signalling high implied enterprise value relative to revenue. The company reports cash per share C$0.00323 and book value per share -C$0.04529, which points to capital shortfalls and negative equity on the balance sheet.

Trading, liquidity and technicals for MYTC.CN stock

Average volume sits at 7,864 while today’s 25,000 shares show a temporary liquidity spike; that matters because the float is concentrated with 31,224,532 shares outstanding. The 50-day average price is C$0.01830 and 200-day average is C$0.06108, indicating a sustained downtrend. Technical indicators show RSI 50.54 and ADX 59.16 suggesting a strong trend; low ATR (0.01) confirms the microcap’s price leaps happen on thin liquidity.

Meyka AI rates MYTC.CN with a score out of 100

Meyka AI rates MYTC.CN with a score of 66.29 / 100, grade B with a HOLD suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics and analyst consensus. We note the model highlights weak liquidity and negative EPS but some doctrinal strength in revenue per share. These grades are not guaranteed and we are not financial advisors.

Meyka AI’s forecast model projects a price outlook

Meyka AI’s forecast model projects a near-term recovery scenario to C$0.020 as a base case, which implies +300.00% from the current C$0.005 price. Forecasts are model-based projections and not guarantees. The model weights sector context, recent trading, and fundamental ratios; downside scenarios include continued microcap illiquidity that would push price toward the year low.

Risks, catalysts and sector context

Primary risks are continued negative EPS, negative book value per share and constrained cash with a current ratio near 0.11, which limits operational runway. Potential catalysts include renewed clinical trial news, distributor deals or funding that materially improves cash per share. The healthcare sector in Canada shows modest short-term gains but MyndTec sits well below sector averages, increasing relative risk versus peers.

Final Thoughts

MYTC.CN stock is trading as a high-risk microcap after a -50.00% intraday move to C$0.005 on 09 Feb 2026. Fundamentals show negative EPS (-0.04) and negative book value per share (-C$0.04529), while trading metrics reveal thin liquidity and a small market cap (C$156,123.00). Meyka AI grades the name 66.29 / 100 (B, HOLD) and models a base-case price of C$0.020, implying +300.00% upside if liquidity and funding improve. Investors should treat this as a speculative situation where the path to any recovery requires clear operational funding or clinical progress. Forecasts are model-based projections and not guarantees. For readers wanting live quotes and alerts we keep MYTC.CN coverage on our AI-powered market analysis platform and monitor filings and volume spikes for new catalysts. For primary documents visit the company site and public data providers linked below.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.